Cancer Immunology
Cancer Immunology refers to the relationship between immune function and cancer. The immunological mechanisms involved in cancer growth are highly complex and provide numerous potential points for intervention with small molecules, including extracellular enzymes, receptors and intracellular signal transduction pathways.
Cancer Immunology Products Targets
- STAT (10)
- PI 3-kinase (22)
- NTPDase (4)
- JAK (10)
- Adenosine A2B Receptor (7)
- Adenosine A2A Receptor (11)
- Toll-like Receptor (11)
- TGF-β Receptor (9)
- STING-Dependent Signaling (1)
- Others (7)
- Chemokine CXC Receptor (9)
- Chemokine CC Receptor (13)
- Purinergic (P2Y) Receptor (31)
- Purinergic (P2X) Receptor (32)
- Prostanoid Receptor (24)
Products for Cancer Immunology - Page 13
- Cat.No. Product Name Information/Activity
-
BCC6004
AR-C 66096 tetrasodium salt
Potent and selective P2Y<sub>12</sub> antagonist
-
BCC2497
Clopidogrel
Clopidogrel hydrogen sulfate is an antiplatelet agent which works by blocking platelets from sticking together and prevents them from forming harmful clots.
-
BCC5685
MRS 2179 tetrasodium salt
1454889-37-2
-
BCC5880
MRS 2279
367909-40-8
-
BCC5881
MRS 2500 tetraammonium salt
630103-23-0
-
BCC4976
MRS 2578
MRS 2578 is a selective and potent P2Y6 receptor antagonist with IC50s of 37 nM (human) and 98 nM (rat). MRS 2578 exhibits insignificant activity at P2Y1, P2Y2, P2Y4, and P2Y11 receptors.
-
BCC7785
NF 340
202982-98-7
-
BCC6095
PSB 0739
1052087-90-7
-
BCC4973
Ticlopidine HCl
Ticlopidine hydrochloride is an adenosine diphosphate (ADP) receptor inhibitor against platelet aggregation with IC50 of ~2 μM.
-
BCC7151
PIT
56583-49-4


